WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--As previously announced on Oct. 31, Merck (NYSE: MRK), known as MSD
outside the United States and Canada, will hold its 2011 full-year and
fourth-quarter sales and earnings conference call with institutional
investors and analysts at 8:00 a.m. EST on Thursday, Feb. 2. During the
call, Kenneth C. Frazier, chairman and chief executive officer; Adam H.
Schechter, president, Global Human Health; and Peter N. Kellogg,
executive vice president and chief financial officer, will provide an
overview of Merck’s business and financial performance.
Investors are invited to a live audio webcast of Merck's fourth-quarter
earnings conference call on Feb. 2 at 8:00 a.m. EST by visiting Merck's
Web site, www.merck.com/investors/events-and-presentations/home.html.
Institutional investors and analysts can participate in the call by
dialing (706) 758-9927 or (877) 381-5782. Journalists are invited to
monitor the call by dialing (706) 758-9928 or (800) 399-7917. A replay
of the call will be available starting Feb. 2 at 11 a.m. EST for
approximately one week. To listen to the replay, dial (404) 537-3406 or
(855) 859-2056 and enter ID No. 23636062.
Today's Merck is a global healthcare leader working to help the world be
well. Merck is known as MSD outside the United States and Canada.
Through our prescription medicines, vaccines, biologic therapies, and
consumer care and animal health products, we work with customers and
operate in more than 140 countries to deliver innovative health
solutions. We also demonstrate our commitment to increasing access to
healthcare through far-reaching policies, programs and partnerships. For
more information, visit www.merck.com
and connect with us on Twitter, Facebook and YouTube.
Merck Media: Ron Rogers, 908-423-6449 or Investors: Carol Ferguson, 908-423-4465